Fig. 3

Kaplan-Meier survival curves illustrating the cumulative revascularization-free survival in patients prescribed DAPT > 6 months compared to those receiving AMT throughout the entire follow-up duration. The AMT group (blue) demonstrates a higher revascularization-free survival rate compared to the DAPT group (purple)